We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEMS icon
8301
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$370M
$970K ﹤0.01%
15,469
-40,221
-72% -$2.43M
ZGNX
8302
DELISTED
Zogenix, Inc.
ZGNX
$970K ﹤0.01%
56,113
-64,254
-53% -$1.18M
FNOV icon
8303
FT Vest US Equity Buffer ETF November
FNOV
$1.24B
$969K ﹤0.01%
25,644
-10,843
-30% -$404K
APRN
8304
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$969K ﹤0.01%
18,858
+11,433
+154% +$727K
VIVO
8305
PUT
DELISTED
Meridian Bioscience Inc
VIVO
$969K ﹤0.01%
43,700
-1,300
-3% -$27.6K
UGL icon
8306
ProShares Ultra Gold
UGL
$790M
$968K ﹤0.01%
67,664
+11,492
+20% +$174K
UVV icon
8307
PUT
Universal Corp
UVV
$1.11B
$968K ﹤0.01%
17,000
+4,300
+34% +$248K
PRFT
8308
DELISTED
Perficient Inc
PRFT
$968K ﹤0.01%
12,033
-142,476
-92% -$10M
HGEN
8309
DELISTED
HUMANIGEN, INC.
HGEN
$968K ﹤0.01%
55,680
-11,642
-17% -$212K
ENDP
8310
CALL
DELISTED
Endo International plc
ENDP
$968K ﹤0.01%
206,900
+77,200
+60% +$443K
CELU icon
8311
CALL
Celularity
CELU
$20.1M
$967K ﹤0.01%
9,500
-3,120
-25% -$316K
LTC
8312
CALL
LTC Properties
LTC
$2.16B
$967K ﹤0.01%
25,200
-4,800
-16% -$195K
BBSI icon
8313
CALL
Barrett Business Services
BBSI
$759M
$966K ﹤0.01%
53,200
+27,200
+105% +$498K
ESRT icon
8314
PUT
Empire State Realty Trust
ESRT
$814M
$966K ﹤0.01%
80,500
+32,100
+66% +$377K
HRTX icon
8315
Heron Therapeutics
HRTX
$57.1M
$966K ﹤0.01%
62,256
-440,222
-88% -$7M
KBWB icon
8316
CALL
Invesco KBW Bank ETF
KBWB
$6.98B
$966K ﹤0.01%
15,000
+3,500
+30% +$230K
SEE
8317
PUT
DELISTED
Sealed Air
SEE
$966K ﹤0.01%
16,300
-31,100
-66% -$1.68M
QEFA icon
8318
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.07B
$965K ﹤0.01%
12,764
-16,228
-56% -$1.22M
DLS icon
8319
WisdomTree International SmallCap Dividend Fund
DLS
$1.07B
$964K ﹤0.01%
12,902
-38,598
-75% -$2.92M
DRIO icon
8320
PUT
DarioHealth
DRIO
$72.1M
$963K ﹤0.01%
2,255
+1,630
+261% +$621K
FORM icon
8321
PUT
FormFactor
FORM
$9.71B
$963K ﹤0.01%
26,400
-8,800
-25% -$347K
CULP icon
8322
PUT
Culp Inc
CULP
$42.6M
$962K ﹤0.01%
59,000
+26,200
+80% +$405K
DAO
8323
PUT
Youdao
DAO
$1.97B
$961K ﹤0.01%
41,600
+5,700
+16% +$138K
SPB icon
8324
PUT
Spectrum Brands
SPB
$2.02B
$961K ﹤0.01%
11,300
-16,200
-59% -$1.43M
TS icon
8325
Tenaris
TS
$26.7B
$961K ﹤0.01%
43,906
-42,982
-49% -$971K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.